Apollo Endosurgery Inc
F:HQ8F
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bizim Toptan Satis Magazalari AS
IST:BIZIM.E
|
TR |
Apollo Endosurgery Inc
Accounts Payable
Apollo Endosurgery Inc
Accounts Payable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Apollo Endosurgery Inc
F:HQ8F
|
Accounts Payable
$7.4m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
22%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Accounts Payable
$1.1B
|
CAGR 3-Years
10%
|
CAGR 5-Years
17%
|
CAGR 10-Years
19%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Accounts Payable
$227.5m
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
13%
|
|
|
Stryker Corp
NYSE:SYK
|
Accounts Payable
$1.8B
|
CAGR 3-Years
8%
|
CAGR 5-Years
17%
|
CAGR 10-Years
16%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Accounts Payable
$4.2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
15%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Accounts Payable
$255.1m
|
CAGR 3-Years
20%
|
CAGR 5-Years
26%
|
CAGR 10-Years
17%
|
|
Apollo Endosurgery Inc
Glance View
Apollo Endosurgery, Inc. is a medical technology company, which focuses on the design, development, and commercialization of medical devices to advance gastrointestinal therapeutic endoscopy. The company is headquartered in West Lake Hills, Texas and currently employs 107 full-time employees. The company went IPO on 2005-04-21. The firm develops and distributes devices that are used by surgeons and gastroenterologists for various procedures related to gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity. The firm's products include the OverStitch Endoscopic Suturing System, which enables advanced endoscopic procedures from within the Gastrointestinal tract, or endolumenally, by allowing physicians to suture, especially full-thickness, and secure the approximation of tissue. The X-Tack Endoscopic HeliX Tacking System is a suture-based device designed specifically for closing and healing defects in the lower gastrointestinal tract. The Orbera Intragastric Balloon System is a non-surgical alternative for interventional weight loss.
See Also
What is Apollo Endosurgery Inc's Accounts Payable?
Accounts Payable
7.4m
USD
Based on the financial report for Dec 31, 2022, Apollo Endosurgery Inc's Accounts Payable amounts to 7.4m USD.
What is Apollo Endosurgery Inc's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
22%
Over the last year, the Accounts Payable growth was 62%. The average annual Accounts Payable growth rates for Apollo Endosurgery Inc have been -9% over the past three years , -17% over the past five years , and 22% over the past ten years .
